v3.25.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of of Servicing Assets at Fair Value

 

Value of intellectual property   $ 44.8 million  
Common shares outstanding (as converted)     1,187,302  
Value per common share   $ 37.71  
Illiquidity discount     20 %
Minority discount     20 %
Fair value of the common stock   $ 22.68  
The following is an analysis of the stock option grant activity

The following is an analysis of the stock option grant activity:

 

          Weighted
Average
    Weighted
Average
 
    Number of
Shares
   

Exercise

Price

    Remaining
Life
 
Stock Options                        
Outstanding December 31, 2024     870,449     $ 5.85       9.19  
Granted                  
Expired                  
Exercised                  
Outstanding March 31, 2025     870,449     $ 5.85       8.94  
Exercisable March 31, 2025     409,679     $ 9.60       8.69  

 

          Weighted
Average
    Weighted
Average
 
    Number    

Exercise

Price

    Remaining
Life
 
Stock Options                        
Outstanding December 31, 2023     197,560     $ 22.68       9.08  
Granted         $        
Expired         $        
Exercised         $        
Outstanding March 31, 2024     197,560     $ 22.68       8.83  
Exercisable March 31, 2024     127,723     $ 22.68       8.83  
A summary of the status of the Company’s nonvested options as of March 31, 2025 and 2024, and changes during three months ended March 31, 2025 and 2024, is presented below

A summary of the status of the Company’s nonvested options as of March 31, 2025 and 2024, and changes during three months ended March 31, 2025 and 2024, is presented below:

 

Non-vested Options   Options     Weighted-
Average
Exercise
Price
 
Non-vested at December 31, 2024     560,928     $ 2.93  
Granted            
Vested     (100,158     4.85  
Forfeited            
Non-vested at March 31, 2025     460,770     $ 2.51  

 

Non-vested Options   Options     Weighted-
Average
Exercise
Price
 
Non-vested at December 31, 2023     113,429     $ 22.68  
Granted          
Vested     (43,592 )   22.68  
Forfeited          
Non-vested at March 31, 2024     69,837     $ 22.68  
The following is an analysis of the stock warrant grant activity

The following is an analysis of the stock warrant grant activity:

 

          Weighted
Average
    Weighted
Average
 
    Number of
Shares
   

Exercise

Price

    Remaining
Life
 
Stock Warrants                        
Outstanding December 31, 2024     55,000     $ 7.50       4.13  
Granted                  
Expired                  
Exercised                  
Outstanding March 31, 2025     55,000     $ 7.50       3.88  
Exercisable March 31, 2025     55,000     $ 7.50       3.88  

 

          Weighted
Average
    Weighted
Average
 
    Number    

Exercise

Price

    Remaining
Life
 
Stock Warrants                        
Outstanding December 31, 2023         $        
Granted     55,000     7.50       4.88  
Expired                
Exercised                
Outstanding March 31, 2024     55,000     $ 7.50       4.88  
Exercisable March 31, 2024     55,000     $ 7.50       4.88  

 

A summary of the status of the Company’s nonvested warrants as of March 31, 2025 and 2024, and changes during the three months ended March 31, 2025 and 2024, is presented below:

 

Non-vested Warrants   Warrants     Weighted-
Average
Exercise
Price
 
Non-vested at December 31, 2024         $  
Granted            
Vested            
Forfeited            
Non-vested at March 31, 2025         $  

 

Non-vested Warrants   Warrants     Weighted-
Average
Exercise
Price
 
Non-vested at December 31, 2023         $  
Granted     55,000     7.50  
Vested     (55,000 )   7.50  
Forfeited          
Non-vested at March 31, 2024         $  
A summary of the status of the Company’s nonvested RSUs as of March 31, 2025, and changes during the three months ended March 31, 2025, is presented below

A summary of the status of the Company’s nonvested RSUs as of March 31, 2025, and changes during the three months ended March 31, 2025, is presented below:

 

Non-vested RSUs   RSUs     Weighted-
Average
Exercise
Price
 
Non-vested at December 31, 2024     292,166     $ 1.08  
Granted          
Vested     (46,345)     (1.10 )
Forfeited          
Non-vested at March 31, 2025     245,821     $ 1.07